Evidence map›Paper›PMID 31922541›Full record

ArticleEuropean heart journal. Quality of care & clinical outcomes2021

Simple risk models to predict cardiovascular death in patients with stable coronary artery disease.

Ian Ford, Michele Robertson, Nicola Greenlaw, Christophe Bauters, Gilles Lemesle, Emmanuel Sorbets, Roberto Ferrari, Jean-Claude Tardif, Michal Tendera, Kim Fox and 2 more

Abstract read
In one paragraph

Article in European heart journal. Quality of care & clinical outcomes, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Prevalence, associated factors, and prognostic value of P wave abnormality in patients with coronary artery disease.International journal of cardiology. Cardiovascular risk and prevention · 2025
    Article
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors.

Ian FordRobertson Centre for Biostatistics, University of Glasgow, Level 11, Boyd Orr Building, Glasgow G12 8QQ, UK.ORCID 0000-0001-5927-1823
Michele RobertsonRobertson Centre for Biostatistics, University of Glasgow, Level 11, Boyd Orr Building, Glasgow G12 8QQ, UK.
Nicola GreenlawRobertson Centre for Biostatistics, University of Glasgow, Level 11, Boyd Orr Building, Glasgow G12 8QQ, UK.
Christophe BautersCardiology Department, Institut Coeur Poumon, CHU, Université de Lille, Bd du Professeur Jules Leclercq, 59000 Lille, France.
Gilles LemesleCardiology Department, Institut Coeur Poumon, CHU, Université de Lille, Bd du Professeur Jules Leclercq, 59000 Lille, France.
Emmanuel SorbetsNational Heart and Lung Institute, Imperial College, Dovehouse Street London SW3 6LY, UK.ORCID 0000-0002-0989-7075
Roberto FerrariCentro Cardiologico Universitario di Ferrara, University of Ferrara, Maria Cecilia Hospital, GVM Care & Research, Via Corriera, 1 48010 Cotignola, Ravenna, Italy.
Jean-Claude TardifMontreal Heart Institute, 5000 Belanger Street, Montreal, H1T1C8, Université de Montréal, Canada.ORCID 0000-0002-8200-8983
Michal TenderaDepartment of Cardiology and Structural Heart Disease, Medical School in Katowice, Medical University of Silesia, Ziolowa Str. 45/47, 40-635 Katowice, Poland.
Kim FoxNational Heart and Lung Institute, Imperial College, Dovehouse Street London SW3 6LY, UK.ORCID 0000-0001-5828-9749
Philippe Gabriel StegNational Heart and Lung Institute, Imperial College, Dovehouse Street London SW3 6LY, UK.
CLARIFY Investigators

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

aimsRisk estimation is important to motivate patients to adhere to treatment and to identify those in whom additional treatments may be warranted and expensive treatments might be most cost effective. Our aim was to develop a simple risk model based on readily available risk factors for patients with stable coronary artery disease (CAD). METHODS AND

resultsModels were developed in the CLARIFY registry of patients with stable CAD, first incorporating only simple clinical variables and then with the inclusion of assessments of left ventricular function, estimated glomerular filtration rate, and haemoglobin levels. The outcome of cardiovascular death over ∼5 years was analysed using a Cox proportional hazards model. Calibration of the models was assessed in an external study, the CORONOR registry of patients with stable coronary disease. We provide formulae for calculation of the risk score and simple integer points-based versions of the scores with associated look-up risk tables. Only the models based on simple clinical variables provided both good c-statistics (0.74 in CLARIFY and 0.80 or over in CORONOR), with no lack of calibration in the external dataset.

conclusionOur preferred model based on 10 readily available variables [age, diabetes, smoking, heart failure (HF) symptom status and histories of atrial fibrillation or flutter, myocardial infarction, peripheral arterial disease, stroke, percutaneous coronary intervention, and hospitalization for HF] had good discriminatory power and fitted well in an external dataset. STUDY REGISTRATION: The CLARIFY registry is registered in the ISRCTN registry of clinical trials (ISRCTN43070564).

Indexed as

Coronary Artery DiseaseMyocardial InfarctionPercutaneous Coronary InterventionHumansRegistriesRisk FactorsCardiovascular deathRisk modelStable coronary artery diseaseValidation

Identifiers

PMID31922541
PMCPMC8092988

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.